Sleep-disordered breathing in patients with heart failure

Area of Science:

• Cardiology
• Pulmonology
• Sleep Medicine

Background:

• Sleep-disordered breathing (SDB) is highly prevalent in heart failure (HF) patients.
• SDB is linked to increased HF morbidity and mortality.
• SDB contributes to a proinflammatory state via nocturnal hypoxia and hypercapnia, promoting oxidative stress and sympathetic activation.

Purpose of the Study:

• To review the impact of SDB on heart failure.
• To highlight SDB as a potential therapeutic target in HF management.
• To discuss the implications of SDB management for HF patient outcomes.

Main Methods:

• Literature review and synthesis of current research on SDB in HF.
• Analysis of the pathophysiological mechanisms linking SDB to HF progression.
• Evaluation of preliminary data on SDB treatment in HF.

Main Results:

• SDB exacerbates HF through proinflammatory pathways, oxidative stress, and sympathetic nervous system activation.
• Preliminary evidence suggests that addressing SDB can improve HF patient outcomes.
• SDB management is an emerging strategy for enhancing HF care.

Conclusions:

• SDB is a significant comorbidity in heart failure with serious consequences.
• Targeting SDB in HF patients holds promise for improved clinical outcomes.
• Further research and clinical attention to SDB in HF are warranted to enhance patient quality of life.